Targeting of BMI-1 with PTC-209 shows potent anti-myeloma activity and impairs the tumour microenvironment

par Bolomsky, Arnold, Schlangen, Karin, Schreiner, Wolfgang, Zojer, Niklas, Ludwig, Heinz
Publié dans J Hematol Oncol (2016)

MCL-1 inhibitors, fast-lane development of a new class of anti-cancer agents

par Bolomsky, Arnold, Vogler, Meike, Köse, Murat Cem, Heckman, Caroline A., Ehx, Grégory, Ludwig, Heinz, Caers, Jo
Publié dans J Hematol Oncol (2020)

Correction to: MCL-1 inhibitors, fast-lane development of a new class of anti-cancer agents

par Bolomsky, Arnold, Vogler, Meike, Köse, Murat Cem, Heckman, Caroline A., Ehx, Grégory, Ludwig, Heinz, Caers, Jo
Publié dans J Hematol Oncol (2021)

Insulin like growth factor binding protein 7 (IGFBP7) expression is linked to poor prognosis but may protect from bone disease in multiple myeloma

par Bolomsky, Arnold, Hose, Dirk, Schreder, Martin, Seckinger, Anja, Lipp, Susanne, Klein, Bernard, Heintel, Daniel, Ludwig, Heinz, Zojer, Niklas
Publié dans J Hematol Oncol (2015)

Maternal embryonic leucine zipper kinase is a novel target for proliferation-associated high-risk myeloma

par Bolomsky, Arnold, Heusschen, Roy, Schlangen, Karin, Stangelberger, Kathrin, Muller, Joséphine, Schreiner, Wolfgang, Zojer, Niklas, Caers, Jo, Ludwig, Heinz
Publié dans Haematologica (2018)

Single-cell exomes in an index case of amp1q21 multiple myeloma reveal more diverse mutanomes than the whole population

par Bryant, Dean, Tapper, Will, Weston-Bell, Nicola J., Bolomsky, Arnold, Song, Li, Xu, Shengtao, Collins, Andrew R., Zojer, Niklas, Sahota, Surinder Singh
Publié dans Blood (2018)

Maternal embryonic leucine zipper kinase inhibitor OTSSP167 has preclinical activity in multiple myeloma bone disease

par Muller, Joséphine, Bolomsky, Arnold, Dubois, Sophie, Duray, Elodie, Stangelberger, Kathrin, Plougonven, Erwan, Lejeune, Margaux, Léonard, Angélique, Marty, Caroline, Hempel, Ute, Baron, Frédéric, Beguin, Yves, Cohen-Solal, Martine, Ludwig, Heinz, Heusschen, Roy, Caers, Jo
Publié dans Haematologica (2018)

Treatment with HIV-Protease Inhibitor Nelfinavir Identifies Membrane Lipid Composition and Fluidity as a Therapeutic Target in Advanced Multiple Myeloma

par Besse, Lenka, Besse, Andrej, Stolze, Sara C., Sobh, Amin, Zaal, Esther A., van der Ham, Alwin J., Ruiz, Mario, Phuyal, Santosh, Büchler, Lorina, Sathianathan, Marc, Florea, Bogdan I., Borén, Jan, Ståhlman, Marcus, Huber, Julia, Bolomsky, Arnold, Ludwig, Heinz, Hannich, J. Thomas, Loguinov, Alex, Everts, Bart, Berkers, Celia R., Pilon, Marc, Farhan, Hesso, Vulpe, Christopher D., Overkleeft, Herman S., Driessen, Christoph
Publié dans Cancer Res (2021)